publication venue for
- Exploring the dynamics of the 2022 mpox outbreak in Canada. 95:e29256. 2023
- Early humoral and cellular responses after bivalent SARS‐CoV‐2 mRNA‐1273.214 vaccination in long‐term care and retirement home residents in Ontario, Canada: An observational cohort study. 95:e29170. 2023
- Evaluating undercounts in epidemics: Response to Maruotti et al. (2022). 95:e28474. 2023
- Application strategies of serum HBV DNA detection in HBV infection patients: A retrospective study of 5611 specimens.. 91:249-257. 2019
- Influenza in patients with hematological malignancies: Experience at two comprehensive cancer centers. 90:50-60. 2018
- Mutation in the S gene of hepatitis B virus and anti-HBs subtype-nonspecificity contributed to the co-existence of HBsAg and anti-HBs in patients with chronic hepatitis B virus infection.. 89:1419-1426. 2017
- Sensitivity of APTIMA HPV E6/E7 mRNA test in comparison with hybrid capture 2 HPV DNA test for detection of high risk oncogenic human papillomavirus in 396 biopsy confirmed cervical cancers. 88:1271-1278. 2016
- Value of a risk scoring tool to predict respiratory syncytial virus disease severity and need for hospitalization in term infants. 87:1285-1291. 2015
- Distribution of human papillomavirus genotypes in cervical intraepithelial neoplasia and invasive cervical cancer in Canada. 83:1034-1041. 2011
- Occult hepatitis B virus infection in the setting of hepatitis C virus (HCV) and human immunodeficiency virus (HIV) co‐infection: Clinically relevant or a diagnostic problem?. 79:694-700. 2007
- Distribution of hepatitis C virus genotypes among hemodialysis patients in Tehran—a multicenter study. 78:569-573. 2006
- Seroprevalence of six different viruses among pregnant women and blood donors in rural and urban Burkina Faso: A comparative analysis. 78:683-692. 2006
- Reverse transcriptase activity for quantitation of HIV-1 subtype C in plasma: Relation to RNA copy number and CD4 T-cell count. 78:161-168. 2006
- Polymorphism of human papillomavirus type 31 isolates infecting the genital tract of HIV‐seropositive and HIV‐seronegative women at risk for HIV infection. 75:213-221. 2005
- Prevalence of selective inhibition of HPV‐16 DNA amplification in cervicovaginal lavages. 72:132-137. 2004
- Parameters of CpG oligodeoxynucleotide‐induced protection against intravaginal HSV‐2 challenge. 71:561-568. 2003
- Seroprevalence and seroincidence of Norwalk-like virus infection among Brazilian infants and children. 61:117-124. 2000
- Phylogenetic analysis of the caliciviruses. 52:419-424. 1997
- Hepatitis E virus infection in hemophiliacs. 46:153-156. 1995
- Replication and cytopathaology of human parvovirus B19 in human umbilical cord blood erythroid progenitor cells. 36:125-130. 1992
- Analysis of a pregnancy‐screening and neonatal‐immunization program for hepatitis B in Hamilton, Ontario, Canada, 1977‐1988. 35:50-54. 1991
- Diagnostic Significance of Anti‐HBcIgM Prevalence Related to Symptoms in Canadian Patients Acutely or Chronically Infected With Hepatitis B Virus. 20:269-277. 1986
- Measurement of BK papovavirus IgG and IgM by radioimmunoassay (RIA). 14:101-114. 1984